2007
DOI: 10.1016/s0377-1237(07)80112-2
|View full text |Cite
|
Sign up to set email alerts
|

Conservative Management of Chronic Renal Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2007
2007
2011
2011

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…There was a statistically significantly higher rate of serious adverse events in the higher vs. lower Hb group. [11] Erythropoietin and thrombosis One of the potential side effects of EPO therapy is an increase in thrombotic events. In a prospective trial, 618 dialysis patients were randomized to achieve a target hematocrit of 42% versus a target hematocrit of greater than 30% in 615 control patients.…”
Section: Correction Of Hemoglobin Outcomes In Renal Insufficiency (Chmentioning
confidence: 99%
“…There was a statistically significantly higher rate of serious adverse events in the higher vs. lower Hb group. [11] Erythropoietin and thrombosis One of the potential side effects of EPO therapy is an increase in thrombotic events. In a prospective trial, 618 dialysis patients were randomized to achieve a target hematocrit of 42% versus a target hematocrit of greater than 30% in 615 control patients.…”
Section: Correction Of Hemoglobin Outcomes In Renal Insufficiency (Chmentioning
confidence: 99%
“…Evidence suggests that appropriate therapy aimed at controlling the common causes namely, diabetes and hypertension results in renal conservation and delays the need for RRT [1,2]. Narula et al [4], in their article appearing in this issue, stress on conservative management of chronic renal failure.…”
mentioning
confidence: 99%